Profit and Loss Results Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is 3.77% vs -14.91% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is -0.07% vs 48.94% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is 54.64% vs -23.90% in Mar 2024
Profit After Tax
YoY Growth in year ended Mar 2025 is -2.38% vs 46.01% in Mar 2024
Compare Profit and Loss Results of Sudeep Pharma
Figures in Cr
standalone - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
356.00
1,029.00
-673.00
-65.40%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
356.00
1,029.00
-673.00
-65.40%
Expenditure (Ex Depriciation)
Stock Adjustments
-20.00
-79.00
59.00
74.68%
Raw Materials Consumed
146.00
540.00
-394.00
-72.96%
Power & Fuel Cost
7.00
24.00
-17.00
-70.83%
Employee Cost
26.00
60.00
-34.00
-56.67%
Operating Expenses
14.00
43.00
-29.00
-67.44%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
26.00
29.00
-3.00
-10.34%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
5.00
18.00
-13.00
-72.22%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
223.00
652.00
-429.00
-65.80%
Operating Profit (PBDIT) excl Other Income
132.00
377.00
-245.00
-64.99%
Other Income
8.00
46.00
-38.00
-82.61%
Operating Profit (PBDIT)
141.00
423.00
-282.00
-66.67%
Interest
5.00
0.00
5.00
0%
Profit before Depriciation and Tax
135.00
423.00
-288.00
-68.09%
Depreciation
6.00
17.00
-11.00
-64.71%
Profit Before Taxation & Exceptional Items
129.00
406.00
-277.00
-68.23%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
129.00
406.00
-277.00
-68.23%
Provision for Tax
33.00
100.00
-67.00
-67.00%
Profit After Tax
95.00
305.00
-210.00
-68.85%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
321.00
810.00
-489.00
-60.37%
Profit Available for appropriations
416.00
1,115.00
-699.00
-62.69%
Appropriations
416.00
1,115.00
-699.00
-62.69%
Equity Dividend (%)
0%
60%
-60.00
Earnings Per Share
8.82
17.59
-8.77
-49.86%
Profit And Loss - Net Sales
Net Sales 356.73 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 3.77% vs -14.91% in Mar 2024
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 132.83 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -0.07% vs 48.94% in Mar 2024
Profit And Loss - Interest
Interest 5.68 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 54.64% vs -23.90% in Mar 2024
Profit And Loss - Profit After Tax
Profit After Tax 95.75 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -2.38% vs 46.01% in Mar 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
